Deaths from breast cancer in Britain and the US have fallen by a quarter
since the late 1980s, report Oxford University epidemiologists in The
Lancet (vol 355, p 1822). The success is put down to earlier detection,
more prompt surgery and the use of hormonal drugs such as tamoxifen. But many
other countries are failing to use tamoxifen widely enough, according to
Christina Davies, one of the team.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
If you aren't terrified by this heatwave, you should be
3
The race to understand how and when Thwaites glacier will collapse
4
Europe鈥檚 heatwave is the hottest and most humid ever
5
Our verdict on The Selfish Gene: An unpopular piece of popular science
6
Most portable air conditioners suck 鈥 but there's an easy fix
7
The surprising ways your brain changes from your 20s to your 40s
8
You should turn off fans when it's too hot 鈥 but how hot is too hot?
9
How menopause radically changes the brain 鈥 and what happens after
10
A promising natural technique to remove CO2 could backfire
